Siglec targeting of Phl p 5a peptides leads to superior suppression of allergic inflammation in vivo

L. Hesse; A. Wellink; W. de Jager; A. Petersen; H. G. de Bruin; M. Ambrosini; Y. van Kooyk; M. C. Nawijn

Publication

Siglec targeting of Phl p 5a peptides leads to superior suppression of allergic inflammation in vivo

Hesse, L., Wellink, A., de Jager, W., Petersen, A., de Bruin, H. G., Ambrosini, M., van Kooyk, Y. & Nawijn, M. C., Aug-2016, In : Allergy. 71, p. 4 1 p.

Research output: Contribution to journal › Meeting Abstract › Academic

Overview
Citation formats

Handle.net

http://hdl.handle.net/11370/d702b02a-869a-4350-b039-93ed47b51b58

L. Hesse
A. Wellink
W. de Jager
A. Petersen
H. G. de Bruin
M. Ambrosini
Y. van Kooyk
M. C. Nawijn

Groningen Research Institute for Asthma and COPD (GRIAC)
Molecular Pharmacology

Original language	English
Pages (from-to)	4
Number of pages	1
Journal	Allergy
Volume	71
Publication status	Published - Aug-2016
Event	Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology - Vienna, Austria Duration: 11-Jun-2016 → 15-Jun-2016

Event

Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology

11/06/2016 → 15/06/2016

Vienna, Austria

Event: Conference

ID: 38576840

University of Groningen staff: edit these data